Literature DB >> 12229989

Sample-size redetermination for repeated measures studies.

David M Zucker1, Jonathan Denne.   

Abstract

Clinical trialists recently have shown interest in two-stage procedures for updating the sample-size calculation at an interim point in a trial. Because many clinical trials involve repeated measures designs, it is desirable to have available practical two-stage procedures for such designs. Shih and Gould (1995, Statistics in Medicine 14, 2239-2248) discuss sample-size redetermination for repeated measures studies but under a highly simplified setup. We develop two-stage procedures under the general mixed linear model, allowing for dropouts and missed visits. We present a range of procedures and compare their Type I error and power by simulation. We find that, in general, the achieved power is brought considerably closer to the required level without inflating the Type I error rate. We also derive an inflation factor that ensures the power requirement is more closely met.

Mesh:

Year:  2002        PMID: 12229989     DOI: 10.1111/j.0006-341x.2002.00548.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Internal pilots for a class of linear mixed models with Gaussian and compound symmetric data.

Authors:  Matthew J Gurka; Christopher S Coffey; Keith E Muller
Journal:  Stat Med       Date:  2007-09-30       Impact factor: 2.373

2.  Internal pilot design for balanced repeated measures.

Authors:  Xinrui Zhang; Keith E Muller; Maureen M Goodenow; Yueh-Yun Chi
Journal:  Stat Med       Date:  2017-11-21       Impact factor: 2.373

3.  Power and Sample Size Calculations for Generalized Estimating Equations via Local Asymptotics.

Authors:  Zhigang Li; Ian W McKeague
Journal:  Stat Sin       Date:  2013-01-01       Impact factor: 1.261

4.  Blinded and unblinded sample size reestimation in crossover trials balanced for period.

Authors:  Michael J Grayling; Adrian P Mander; James M S Wason
Journal:  Biom J       Date:  2018-08-03       Impact factor: 2.207

5.  Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study.

Authors:  Julie Wych; Michael J Grayling; Adrian P Mander
Journal:  Trials       Date:  2019-12-02       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.